SPATA2 and colorectal carcinoma: Further analyses of SPATA2 in TCGA genomics data revealed that SPATA2 expression is negatively correlated with that of CXCL9/10/11 and GEP in CRC tumors (Figure 1B) and often elevated in tumors relative to healthy colons in Genotype-Tissue Expression (GTEx) (Figure 1C).